id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-0811-0153,FDA,FDA-2013-D-0811,Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation To Treat Clostridioides difficile Infection Not Responsive to Standard Therapies; Guidance for Industry; Availability,Notice,Notice of Availability,2022-11-29T05:00:00Z,2022,11,2022-11-29T05:00:00Z,,2022-11-29T15:13:37Z,2022-26000,0,0,0900006485507229
FDA-2013-D-0811-0154,FDA,FDA-2013-D-0811,Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridioides difficile Infection Not Responsive to Standard Therapies,Other,Guidance,2022-11-29T05:00:00Z,2022,11,2022-11-29T05:00:00Z,,2024-11-12T23:47:21Z,,1,0,09000064855086d2